Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype

Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype

Weitere Versionen anzeigen (1)

Bibliographische Detailangaben
Hauptverfasser:	Burns, A, Clifford, R, Dreau, H, Hatton, C, Henderson, S, Taylor, J, Schuh, A
Format:	Conference item
Veröffentlicht:	2012

Ähnliche Einträge

Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype
von: Burns, A, et al.
Veröffentlicht: (2012)

SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features
von: Clifford, R, et al.
Veröffentlicht: (2012)

MicroRNA expression in chronic lymphocytic leukaemia.
von: Lawrie, C, et al.
Veröffentlicht: (2009)

Using genomic information to guide ibrutinib treatment decisions in chronic lymphocytic leukaemia: a cost-effectiveness analysis
von: Buchanan, J, et al.
Veröffentlicht: (2017)

Progressive multifocal leukoencephalopathy as the presenting feature of chronic lymphocytic leukaemia.
von: Bruce, DR, et al.
Veröffentlicht: (2014)

Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia.
von: Oscier, D, et al.
Veröffentlicht: (2012)

Patients’ preferences for genomic diagnostic testing in chronic lymphocytic leukaemia: a discrete choice experiment
von: Buchanan, J, et al.
Veröffentlicht: (2016)

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV(mut) and IgHV(unmut) subgroups
von: Burns, A, et al.
Veröffentlicht: (2017)

Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia.
von: Rees-Unwin, K, et al.
Veröffentlicht: (2010)

Nine Novel Mutations in the Erythroid Transcription Factor KLF1 Gene Associated with Increased Fetal Hemoglobin Levels in Adults
von: Gallienne, A, et al.
Veröffentlicht: (2011)

HEMATOLOGICAL MALIGNANCIES. LYMPHOCYTIC LEUKAEMIA
von: Peter F. Litvitsky, et al.
Veröffentlicht: (2016-11-01)

The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL)
von: Michał K. Zarobkiewicz, et al.
Veröffentlicht: (2022-02-01)

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
von: Parker, H, et al.
Veröffentlicht: (2016)

The value of subtyping in studies of irradiation and human leukaemia.
von: Darby, S
Veröffentlicht: (1985)

Immunoglobulin replacement in chronic lymphocytic leukaemia.
von: Bunch, C
Veröffentlicht: (1988)

Chronic lymphocytic leukaemia: An immunobiology approach
von: Kostareli Efterpi, et al.
Veröffentlicht: (2008-01-01)

Quantitative Whole Genome Analysis of Sequential Samples From Patients with B-CLL Identifies Novel Recurrent Copy Number Alterations Involving Critical B-Cell Transcription Factors
von: Timbs, A, et al.
Veröffentlicht: (2010)

Quantitative Whole Genome Analysis of Sequential Samples From Patients with B CLL Identifies Novel Recurrent Copy Number Alterations Involving Critical B Cell Transcription Factors
von: Timbs, A, et al.
Veröffentlicht: (2010)

Concurrence of chronic lymphocytic leukaemia/small lymphocytic lymphoma and acute myeloid leukaemia in a bone marrow biopsy
von: Stefano Licci
Veröffentlicht: (2020-10-01)

p53 expression in chronic lymphocytic leukaemia
von: Nasir AL-Allawi, et al.
Veröffentlicht: (2005-07-01)

A case of leukaemia cutis in a dog with T‐cell chronic lymphocytic leukaemia
von: Hyeona Bae, et al.
Veröffentlicht: (2022-05-01)

Stomach Cancer in a Patient with Chronic Lymphocytic Leukaemia
von: R. A. Maier, et al.
Veröffentlicht: (2019-07-01)

Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.
von: Chowdhury, O, et al.
Veröffentlicht: (2011)

Cutaneous Mycobacterium chelonae infection in chronic lymphocytic leukaemia
von: M Dungarwalla, et al.
Veröffentlicht: (2007-01-01)

Chronic lymphocytic leukaemia and prolymphocytic leukaemia. Two coins or two sides of the same coin?
von: Laura Magnano, et al.
Veröffentlicht: (2020-06-01)

Intravenous immune globulin in chronic lymphocytic leukaemia.
von: Gamm, H, et al.
Veröffentlicht: (1994)

Predictors of infection in chronic lymphocytic leukaemia (CLL).
von: Griffiths, H, et al.
Veröffentlicht: (1992)

Chronic lymphocytic leukaemia with concomitant plasmablastic lymphoma
von: Jacqueline Goedhals, et al.
Veröffentlicht: (2017-03-01)

Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival
von: Flora Nguyen Van Long, et al.
Veröffentlicht: (2023-12-01)

State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.
von: Clifford, R, et al.
Veröffentlicht: (2012)

The study of DNA methylation anomalies in chronic lymphocytic leukaemia
von: Roy, NBA
Veröffentlicht: (2011)

Colonic Involvement in a Patient with Chronic Lymphocytic Leukaemia
von: P. E. T. Arkkila, et al.
Veröffentlicht: (2008-01-01)

Perspectives on the Application of Cytogenomic Approaches in Chronic Lymphocytic Leukaemia
von: Wan Norizzati Wan Mohamad Zamri, et al.
Veröffentlicht: (2023-03-01)

Whipple's Disease as the First Manifestation of Chronic Lymphocytic Leukaemia
von: Verónica Botelho Guiomar, et al.
Veröffentlicht: (2019-09-01)

Thyroid nodule: first manifestation of chronic lymphocytic leukaemia
von: Ana Gonçalves, et al.

Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
von: J Dretzke, et al.
Veröffentlicht: (2010-10-01)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
von: Knight, S, et al.
Veröffentlicht: (2012)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
von: Knight, S, et al.
Veröffentlicht: (2012)

Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia
von: S Walker, et al.
Veröffentlicht: (2009-06-01)

PB1859: DEFINING T-CELL POPULATIONS IN CHRONIC LYMPHOCYTIC LEUKAEMIA
von: A. Mora, et al.
Veröffentlicht: (2022-06-01)